Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus
Hegab, N., Attia, M., Shaker, O. (2022). Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus. EKB Journal Management System, 9(1), 113-120. doi: 10.21608/adjg.2021.48111.1316
Nora F. Hegab; Mai S. Attia; Olfat G. Shaker. "Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus". EKB Journal Management System, 9, 1, 2022, 113-120. doi: 10.21608/adjg.2021.48111.1316
Hegab, N., Attia, M., Shaker, O. (2022). 'Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus', EKB Journal Management System, 9(1), pp. 113-120. doi: 10.21608/adjg.2021.48111.1316
Hegab, N., Attia, M., Shaker, O. Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus. EKB Journal Management System, 2022; 9(1): 113-120. doi: 10.21608/adjg.2021.48111.1316

Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus

Al-Azhar Dental Journal for Girls
Article 13, Volume 9, Issue 1, January 2022, Page 113-120  XML PDF (396.16 K)
Document Type: Original Article
DOI: 10.21608/adjg.2021.48111.1316
View on SCiNiTO View on SCiNiTO
Authors
Nora F. Hegab email 1; Mai S. Attia2; Olfat G. Shaker3
1B. D. S. (2012) Faculty of Dentistry, Modern Sciences and Arts (MSA) University, Cairo, Egypt.
2Associate Professor of Oral Medicine, Periodontology, Diagnosis and Radiology department, Faculty of Dental Medicine for Girls, Al-Azhar University, Cairo, Egypt.
3Professor of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Abstract
Purpose: This study was designed to evaluate the resistin levels in gingival crevicular fluid (GCF) of patients suffering from periodontitis and type II diabetes mellitus (TIIDM) after non-surgical periodontal therapy and Azithromycin (AZM) as adjunctive therapy. Subjects and Methods: 48 patients with periodontitis their age ranging between (20-50) years old were selected for this study were divided into three groups: (group I): healthy patients with periodontitis, (group II): controlled TIIDM patients with periodontitis, and (group III): controlled TIIDM patients with periodontitis who were received AZM. All patients received non-surgical periodontal therapy (NSPT) and were examined with the following clinical periodontal parameters which are plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level (CAL) at baseline, 1 month and 3 months. Collection of GCF samples was done in all patients at baseline, 4 weeks and 6 weeks. Following the periodontal therapy. Quantification of resistin in human samples was measured using resistin ELISA test. Results: NSPT was found to show relative improvement in all clinical parameters as well as a decline in resistin levels. In addition, GCF levels of resistin, GI and PI showed greater reduction after non-surgical treatment in group III than group I and II with non- significant difference. Conclusion: NSPT is found to be effective in the management of periodontitis patients with and without diabetes mellitus and also GCF resistin can be a potential biomarker to detect the periodontal disease condition. Also, adjunctive use of AZM showed clinical benefit to patients with periodontitis by its role on host response modulation.
Keywords
Periodontitis; Diabetes Mellitus; Resistin; Azithromycin
Statistics
Article View: 153
PDF Download: 180